SC
CADL icon

Steven Cohen’s Candel Therapeutics CADL Stock Holding History

Steven Cohen’s Portfolio CADL Stock Details CADL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.33M Buy
129,183
+21,972
+20% +$166K ﹤0.01% 2654
2026
Q1 		$525K Buy
+107,211
New +$583K ﹤0.01% 3096
2022
Q4 		– Sell
-403,131
Closed -$1.27M – 1527
2022
Q3 		$1.27M Sell
403,131
-339,951
-46% -$1.15M 0.01% 1014
2022
Q2 		$2.41M Buy
+743,082
New +$2.98M 0.01% 894

Other funds holding CADL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Steven Cohen's CADL Position: Q2 2026 in Review

Steven Cohen increased its Candel Therapeutics (CADL) stake by 20% in Q2 2026, buying an estimated $166K and bringing the position to 129,183 shares worth $1.33M. The position accounts for ﹤0.01% of the portfolio, ranked #2654.

Steven Cohen first reported a position in CADL in Q2 2022 and has held it in 4 quarters since. The position peaked at $2.41M in Q2 2022. 137 funds tracked by Wall St. Rank hold CADL as of Q2 2026.

  • Steven Cohen held 129,183 shares of Candel Therapeutics worth $1.33M as of Q2 2026.
  • Steven Cohen bought 21,972 Candel Therapeutics shares in Q2 2026, an estimated $166K.
  • Candel Therapeutics made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #2654 holding.
  • Steven Cohen first reported a position in Candel Therapeutics in Q2 2022 and has held it in 4 quarters since.
  • Steven Cohen's Candel Therapeutics position peaked at $2.41M in Q2 2022.
  • 137 funds tracked by Wall St. Rank held Candel Therapeutics as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.